The nonviral episomal replicating vector pEPI-1 allows long-term inhibition of bcr-abl expression by shRNA

The inhibition of gene expression by RNA interference harbors a high potential for application in the therapy of human diseases. However, while exogenous application of siRNAs efficiently inhibits gene expression, these effects are only transient in mammalian cells. We designed a short hairpin RNA-e...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Human gene therapy 2005-04, Vol.16 (4), p.533-539
Hauptverfasser: JENKE, Andreas C. W, EISENBERGER, Tobias, BAIKER, Armin, STEHLE, Isa M, WIRTH, Stefan, LIPPS, Hans Joachim
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 539
container_issue 4
container_start_page 533
container_title Human gene therapy
container_volume 16
creator JENKE, Andreas C. W
EISENBERGER, Tobias
BAIKER, Armin
STEHLE, Isa M
WIRTH, Stefan
LIPPS, Hans Joachim
description The inhibition of gene expression by RNA interference harbors a high potential for application in the therapy of human diseases. However, while exogenous application of siRNAs efficiently inhibits gene expression, these effects are only transient in mammalian cells. We designed a short hairpin RNA-expression cassette to target the bcr-abl oncogene that was then introduced into the nonviral vector system pEPI-1, which replicates episomally in the absence of selection in the bcr-abl-positive cell line K562. Forty-two days after transfection the bcr-abl- but not the cytokine-dependent growth rate was found to be drastically reduced in K562 cells. Western analysis revealed a more than 90% reduction in the expression of the fusion protein bcr-abl while the expression of the bcr protein remained unaffected. In addition, we show that the level of bcr-abl mRNA was specifically reduced in these cells for more than 90%. These results demonstrate that the vector system pEPI-1 allows specific and efficient long term gene suppression by using a short hairpin RNA transcription unit.
doi_str_mv 10.1089/hum.2005.16.533
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_67805794</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>17864936</sourcerecordid><originalsourceid>FETCH-LOGICAL-c356t-54365f9e240ecdef6e5243f405a3facd7979ee2b257a6f9567c00e2403028fe33</originalsourceid><addsrcrecordid>eNqFkb1PHDEQxa0oUSAkdTrkJun28Le9JUKQICGIIlJbXt-YM_KuF3uPj_8-PnESJdU8jX7zNDMPoe-UrCgx_clmO64YIXJF1Upy_gEdUil1pwVjH5smgneEC3aAvtR6TwjlUunP6IBKo6ky8hDd324AT3l6jMUlDHOseWyiwJyid0uc7vAj-CUXPJ__uewodinlp4pTnu66BcqI47SJQ1xinnAOePClc0Nzep4L1LrrDi-4bv5en35Fn4JLFb7t6xH6d3F-e_a7u7r5dXl2etX5tt3SScGVDD0wQcCvISiQTPAgiHQ8OL_Wve4B2MCkdir07SBPyI7mhJkAnB-hn6--c8kPW6iLHWP1kJKbIG-rVdoQqXvxLki1UaLnqoEnr6AvudYCwc4ljq68WErsLgfbcrC7HCxVtuXQJo731tthhPUbv398A37sAVe9S6G4ycf6xiktjTGM_wfQqpEG</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>17864936</pqid></control><display><type>article</type><title>The nonviral episomal replicating vector pEPI-1 allows long-term inhibition of bcr-abl expression by shRNA</title><source>Mary Ann Liebert Online Subscription</source><source>MEDLINE</source><creator>JENKE, Andreas C. W ; EISENBERGER, Tobias ; BAIKER, Armin ; STEHLE, Isa M ; WIRTH, Stefan ; LIPPS, Hans Joachim</creator><creatorcontrib>JENKE, Andreas C. W ; EISENBERGER, Tobias ; BAIKER, Armin ; STEHLE, Isa M ; WIRTH, Stefan ; LIPPS, Hans Joachim</creatorcontrib><description>The inhibition of gene expression by RNA interference harbors a high potential for application in the therapy of human diseases. However, while exogenous application of siRNAs efficiently inhibits gene expression, these effects are only transient in mammalian cells. We designed a short hairpin RNA-expression cassette to target the bcr-abl oncogene that was then introduced into the nonviral vector system pEPI-1, which replicates episomally in the absence of selection in the bcr-abl-positive cell line K562. Forty-two days after transfection the bcr-abl- but not the cytokine-dependent growth rate was found to be drastically reduced in K562 cells. Western analysis revealed a more than 90% reduction in the expression of the fusion protein bcr-abl while the expression of the bcr protein remained unaffected. In addition, we show that the level of bcr-abl mRNA was specifically reduced in these cells for more than 90%. These results demonstrate that the vector system pEPI-1 allows specific and efficient long term gene suppression by using a short hairpin RNA transcription unit.</description><identifier>ISSN: 1043-0342</identifier><identifier>EISSN: 1557-7422</identifier><identifier>DOI: 10.1089/hum.2005.16.533</identifier><identifier>PMID: 15871685</identifier><identifier>CODEN: HGTHE3</identifier><language>eng</language><publisher>Larchmont, NY: Liebert</publisher><subject>Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy ; Applied cell therapy and gene therapy ; Base Sequence ; Biological and medical sciences ; Biotechnology ; Blotting, Northern ; Blotting, Western ; Cell Proliferation ; Cytokines - metabolism ; DNA Polymerase III - genetics ; Fundamental and applied biological sciences. Psychology ; Fusion Proteins, bcr-abl - drug effects ; Fusion Proteins, bcr-abl - genetics ; Gene Expression Regulation - drug effects ; Gene therapy ; Genetic Vectors - genetics ; Genetic Vectors - pharmacology ; Health. Pharmaceutical industry ; Humans ; Industrial applications and implications. Economical aspects ; K562 Cells ; Medical sciences ; Molecular Sequence Data ; Plasmids - genetics ; Promoter Regions, Genetic ; RNA - chemistry ; RNA - genetics ; RNA - pharmacology ; RNA, Catalytic - chemistry ; Transfusions. Complications. Transfusion reactions. Cell and gene therapy ; Virus Replication - genetics</subject><ispartof>Human gene therapy, 2005-04, Vol.16 (4), p.533-539</ispartof><rights>2005 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c356t-54365f9e240ecdef6e5243f405a3facd7979ee2b257a6f9567c00e2403028fe33</citedby><cites>FETCH-LOGICAL-c356t-54365f9e240ecdef6e5243f405a3facd7979ee2b257a6f9567c00e2403028fe33</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,777,781,3029,27905,27906</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=16758882$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/15871685$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>JENKE, Andreas C. W</creatorcontrib><creatorcontrib>EISENBERGER, Tobias</creatorcontrib><creatorcontrib>BAIKER, Armin</creatorcontrib><creatorcontrib>STEHLE, Isa M</creatorcontrib><creatorcontrib>WIRTH, Stefan</creatorcontrib><creatorcontrib>LIPPS, Hans Joachim</creatorcontrib><title>The nonviral episomal replicating vector pEPI-1 allows long-term inhibition of bcr-abl expression by shRNA</title><title>Human gene therapy</title><addtitle>Hum Gene Ther</addtitle><description>The inhibition of gene expression by RNA interference harbors a high potential for application in the therapy of human diseases. However, while exogenous application of siRNAs efficiently inhibits gene expression, these effects are only transient in mammalian cells. We designed a short hairpin RNA-expression cassette to target the bcr-abl oncogene that was then introduced into the nonviral vector system pEPI-1, which replicates episomally in the absence of selection in the bcr-abl-positive cell line K562. Forty-two days after transfection the bcr-abl- but not the cytokine-dependent growth rate was found to be drastically reduced in K562 cells. Western analysis revealed a more than 90% reduction in the expression of the fusion protein bcr-abl while the expression of the bcr protein remained unaffected. In addition, we show that the level of bcr-abl mRNA was specifically reduced in these cells for more than 90%. These results demonstrate that the vector system pEPI-1 allows specific and efficient long term gene suppression by using a short hairpin RNA transcription unit.</description><subject>Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy</subject><subject>Applied cell therapy and gene therapy</subject><subject>Base Sequence</subject><subject>Biological and medical sciences</subject><subject>Biotechnology</subject><subject>Blotting, Northern</subject><subject>Blotting, Western</subject><subject>Cell Proliferation</subject><subject>Cytokines - metabolism</subject><subject>DNA Polymerase III - genetics</subject><subject>Fundamental and applied biological sciences. Psychology</subject><subject>Fusion Proteins, bcr-abl - drug effects</subject><subject>Fusion Proteins, bcr-abl - genetics</subject><subject>Gene Expression Regulation - drug effects</subject><subject>Gene therapy</subject><subject>Genetic Vectors - genetics</subject><subject>Genetic Vectors - pharmacology</subject><subject>Health. Pharmaceutical industry</subject><subject>Humans</subject><subject>Industrial applications and implications. Economical aspects</subject><subject>K562 Cells</subject><subject>Medical sciences</subject><subject>Molecular Sequence Data</subject><subject>Plasmids - genetics</subject><subject>Promoter Regions, Genetic</subject><subject>RNA - chemistry</subject><subject>RNA - genetics</subject><subject>RNA - pharmacology</subject><subject>RNA, Catalytic - chemistry</subject><subject>Transfusions. Complications. Transfusion reactions. Cell and gene therapy</subject><subject>Virus Replication - genetics</subject><issn>1043-0342</issn><issn>1557-7422</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2005</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkb1PHDEQxa0oUSAkdTrkJun28Le9JUKQICGIIlJbXt-YM_KuF3uPj_8-PnESJdU8jX7zNDMPoe-UrCgx_clmO64YIXJF1Upy_gEdUil1pwVjH5smgneEC3aAvtR6TwjlUunP6IBKo6ky8hDd324AT3l6jMUlDHOseWyiwJyid0uc7vAj-CUXPJ__uewodinlp4pTnu66BcqI47SJQ1xinnAOePClc0Nzep4L1LrrDi-4bv5en35Fn4JLFb7t6xH6d3F-e_a7u7r5dXl2etX5tt3SScGVDD0wQcCvISiQTPAgiHQ8OL_Wve4B2MCkdir07SBPyI7mhJkAnB-hn6--c8kPW6iLHWP1kJKbIG-rVdoQqXvxLki1UaLnqoEnr6AvudYCwc4ljq68WErsLgfbcrC7HCxVtuXQJo731tthhPUbv398A37sAVe9S6G4ycf6xiktjTGM_wfQqpEG</recordid><startdate>20050401</startdate><enddate>20050401</enddate><creator>JENKE, Andreas C. W</creator><creator>EISENBERGER, Tobias</creator><creator>BAIKER, Armin</creator><creator>STEHLE, Isa M</creator><creator>WIRTH, Stefan</creator><creator>LIPPS, Hans Joachim</creator><general>Liebert</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QO</scope><scope>7TM</scope><scope>8FD</scope><scope>FR3</scope><scope>P64</scope><scope>7X8</scope></search><sort><creationdate>20050401</creationdate><title>The nonviral episomal replicating vector pEPI-1 allows long-term inhibition of bcr-abl expression by shRNA</title><author>JENKE, Andreas C. W ; EISENBERGER, Tobias ; BAIKER, Armin ; STEHLE, Isa M ; WIRTH, Stefan ; LIPPS, Hans Joachim</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c356t-54365f9e240ecdef6e5243f405a3facd7979ee2b257a6f9567c00e2403028fe33</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2005</creationdate><topic>Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy</topic><topic>Applied cell therapy and gene therapy</topic><topic>Base Sequence</topic><topic>Biological and medical sciences</topic><topic>Biotechnology</topic><topic>Blotting, Northern</topic><topic>Blotting, Western</topic><topic>Cell Proliferation</topic><topic>Cytokines - metabolism</topic><topic>DNA Polymerase III - genetics</topic><topic>Fundamental and applied biological sciences. Psychology</topic><topic>Fusion Proteins, bcr-abl - drug effects</topic><topic>Fusion Proteins, bcr-abl - genetics</topic><topic>Gene Expression Regulation - drug effects</topic><topic>Gene therapy</topic><topic>Genetic Vectors - genetics</topic><topic>Genetic Vectors - pharmacology</topic><topic>Health. Pharmaceutical industry</topic><topic>Humans</topic><topic>Industrial applications and implications. Economical aspects</topic><topic>K562 Cells</topic><topic>Medical sciences</topic><topic>Molecular Sequence Data</topic><topic>Plasmids - genetics</topic><topic>Promoter Regions, Genetic</topic><topic>RNA - chemistry</topic><topic>RNA - genetics</topic><topic>RNA - pharmacology</topic><topic>RNA, Catalytic - chemistry</topic><topic>Transfusions. Complications. Transfusion reactions. Cell and gene therapy</topic><topic>Virus Replication - genetics</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>JENKE, Andreas C. W</creatorcontrib><creatorcontrib>EISENBERGER, Tobias</creatorcontrib><creatorcontrib>BAIKER, Armin</creatorcontrib><creatorcontrib>STEHLE, Isa M</creatorcontrib><creatorcontrib>WIRTH, Stefan</creatorcontrib><creatorcontrib>LIPPS, Hans Joachim</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Biotechnology Research Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Human gene therapy</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>JENKE, Andreas C. W</au><au>EISENBERGER, Tobias</au><au>BAIKER, Armin</au><au>STEHLE, Isa M</au><au>WIRTH, Stefan</au><au>LIPPS, Hans Joachim</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The nonviral episomal replicating vector pEPI-1 allows long-term inhibition of bcr-abl expression by shRNA</atitle><jtitle>Human gene therapy</jtitle><addtitle>Hum Gene Ther</addtitle><date>2005-04-01</date><risdate>2005</risdate><volume>16</volume><issue>4</issue><spage>533</spage><epage>539</epage><pages>533-539</pages><issn>1043-0342</issn><eissn>1557-7422</eissn><coden>HGTHE3</coden><abstract>The inhibition of gene expression by RNA interference harbors a high potential for application in the therapy of human diseases. However, while exogenous application of siRNAs efficiently inhibits gene expression, these effects are only transient in mammalian cells. We designed a short hairpin RNA-expression cassette to target the bcr-abl oncogene that was then introduced into the nonviral vector system pEPI-1, which replicates episomally in the absence of selection in the bcr-abl-positive cell line K562. Forty-two days after transfection the bcr-abl- but not the cytokine-dependent growth rate was found to be drastically reduced in K562 cells. Western analysis revealed a more than 90% reduction in the expression of the fusion protein bcr-abl while the expression of the bcr protein remained unaffected. In addition, we show that the level of bcr-abl mRNA was specifically reduced in these cells for more than 90%. These results demonstrate that the vector system pEPI-1 allows specific and efficient long term gene suppression by using a short hairpin RNA transcription unit.</abstract><cop>Larchmont, NY</cop><pub>Liebert</pub><pmid>15871685</pmid><doi>10.1089/hum.2005.16.533</doi><tpages>7</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1043-0342
ispartof Human gene therapy, 2005-04, Vol.16 (4), p.533-539
issn 1043-0342
1557-7422
language eng
recordid cdi_proquest_miscellaneous_67805794
source Mary Ann Liebert Online Subscription; MEDLINE
subjects Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy
Applied cell therapy and gene therapy
Base Sequence
Biological and medical sciences
Biotechnology
Blotting, Northern
Blotting, Western
Cell Proliferation
Cytokines - metabolism
DNA Polymerase III - genetics
Fundamental and applied biological sciences. Psychology
Fusion Proteins, bcr-abl - drug effects
Fusion Proteins, bcr-abl - genetics
Gene Expression Regulation - drug effects
Gene therapy
Genetic Vectors - genetics
Genetic Vectors - pharmacology
Health. Pharmaceutical industry
Humans
Industrial applications and implications. Economical aspects
K562 Cells
Medical sciences
Molecular Sequence Data
Plasmids - genetics
Promoter Regions, Genetic
RNA - chemistry
RNA - genetics
RNA - pharmacology
RNA, Catalytic - chemistry
Transfusions. Complications. Transfusion reactions. Cell and gene therapy
Virus Replication - genetics
title The nonviral episomal replicating vector pEPI-1 allows long-term inhibition of bcr-abl expression by shRNA
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-20T06%3A27%3A57IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20nonviral%20episomal%20replicating%20vector%20pEPI-1%20allows%20long-term%20inhibition%20of%20bcr-abl%20expression%20by%20shRNA&rft.jtitle=Human%20gene%20therapy&rft.au=JENKE,%20Andreas%20C.%20W&rft.date=2005-04-01&rft.volume=16&rft.issue=4&rft.spage=533&rft.epage=539&rft.pages=533-539&rft.issn=1043-0342&rft.eissn=1557-7422&rft.coden=HGTHE3&rft_id=info:doi/10.1089/hum.2005.16.533&rft_dat=%3Cproquest_cross%3E17864936%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=17864936&rft_id=info:pmid/15871685&rfr_iscdi=true